Boston Scientific Corp. (BSX) News
Filter BSX News Items
BSX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BSX News Highlights
- BSX's 30 day story count now stands at 22.
- Over the past 27 days, BSX's stories per day has been in a clear uptrend, growing by about 0.14 per day.
- CVS, TOP and DRUG are the most mentioned tickers in articles about BSX.
Latest BSX News From Around the Web
Below are the latest news stories about BOSTON SCIENTIFIC CORP that investors may wish to consider to help them evaluate BSX as an investment opportunity.
The Zacks Analyst Blog Highlights Amazon.com, Boeing, Regeneron, Boston Scientific and Waste ManagementAmazon.com, Boeing, Regeneron, Boston Scientific and Waste Management are part of the Zacks top Analyst Blog. |
Boston Scientific (BSX) Set to Acquire Relievant MedsystemsBoston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio. |
What Is the Boston Scientific Foundation?NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Boston ScientificAs a leader in health care, Boston Scientific is dedicated to creating healthier communities in a wealth of ways, including large-scale programs like Close the Gap that help increase ... |
CVS Health appoints Michael F. Mahoney to its Board of DirectorsCVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1. |
Boston Scientific Offers Bullish Guidance And Briefly Breaks OutBoston Scientific kicked off its Investor Day on Wednesday, a day after announcing its Relievant buyout, and BSX stock jumped. |
Is Boston Scientific (BSX) Priced Right? A Comprehensive Guide to Its Market ValueUnveiling the True Worth of Boston Scientific (BSX) Through a Detailed Analysis of Its Valuation and Financial Performance |
Health Care Roundup: Market TalkFind insight on Boston Scientific, Praxis Precision Medicines, Pfizer, and more in the latest Market Talks covering the Health Care sector. |
6 Growth Stocks That Look Recession-Resistant, According to Morgan StanleyApple, Boston Scientific, Costco, Monster Beverage, UnitedHealth, and Colgate-Palmolive shares could still rise in the face of a consumer-spending slump, says Morgan Stanley. |
Midday movers: Instacart, AutoZone, Target and moreInvesting.com -- U.S. were falling on Tuesday as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come. |
UPDATE 2-Boston Scientific to buy chronic back pain therapy maker RelievantMedical devices maker Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years. The deal is the latest in a string of acquisitions by Boston Scientific, which makes pacemakers, stents and catheters, to boost its portfolio of devices. |